Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture

ConditionsDupuytren Contracture Dupuytren's Disease Contracture Joint Diseases Musculoskeletal Diseases Fibroma Neoplasm, Fibrous Tissue Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type Neoplasms Connective Tissue Diseases

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age45-99

SponsorRegionshospitalet Silkeborg

About this trial

Comparing percutaneous needle fasciotomy +/- corticosteroid injection for Dupuytren's contracture affecting metacarpophalangeal joints. A clinician-initiated, multicenter, randomized controlled trial.

Eligibility criteria

Qualifiers

Dupuytren contracture (DC) of ≥ 20° PED in MCP joint measured with a goniometer

DC of either II-V finger

Well-defined/palpable cord

Disqualifiers

Legally incapacitated

Previous study inclusion with another finger ray

Isolated proximal interphalangeal (PIP) or distal interphalangeal (DIP) joint contracture, defined as MCP joint contracture < 20° PED regardless of the deficit in the PIP or DIP joint

Previous hand surgery of the affected finger for any reason

Trial design

Treatments tested in this trial

Percutaneous needle fasciotomy
Corticosteroid injection
Saline injection

Treatment groups

400 Participants

are divided into 2 treatment groups

Locations

Silkeborg Regional Hospital8600, Silkeborg Denmark

Sponsors and collaborators

Regionshospitalet Silkeborg

Lead sponsor

Source ClinicalTrials.gov